437
Views
3
CrossRef citations to date
0
Altmetric
Priority Paper Evaluation

Long-term effects of trans fatty acid intake during pregnancy and lactation: does it have deleterious consequences?

&
Pages 489-494 | Published online: 18 Jan 2017

Bibliography

  • Pisani LP, Oller do Nascimento CM,Bueno AA et al.: Hydrogenated fat diet in take during pregnancy and lactation modifies the PAI-1 gene expression in whiteadipose tissue of offspring in adult life.Lipids Health Dis. 7, 13 (2008).
  • Lumey LH, Ravelli AC, Wiessing LG,Koppe JG, Treffers PE, Stein ZA: The Dutch Famine Birth Cohort study: design,validation of exposure, and selected characteristics of subjects after 43 yearsfollow-up. Paediatr. Perinat. Epidemiol. 7,354–;367 (1993).
  • Ravelli AC, van der Meulen JH, Michels RPet al.: Glucose tolerance in adults afterprenatal exposure to famine. Lancet 351,173–177 (1998).
  • Ravelli GP, Stein ZA, Susser MW: Obesity in young men after famine exposure in uteroand early infancy. N. Engl. J. Med. 295,349–353 (1976).
  • Ravelli AC, van Der Meulen JH,Osmond C, Barker DJ, Bleker OP:Obesity at the age of 50 years in men andwomen exposed to famine prenatally.Am. J. Clin. Nutr. 70, 811–816(1999).
  • Ibrahim A, Natrajan S, Ghafoorunissa R:Dietary trans-fatty acids alter adipocyteplasma membrane fatty acid composition and insulin sensitivity in rats. Metabolism54, 240–246 (2005).
  • Lichtenstein AH, Erkkila AT, Lamarche B,Schwab US, Jalbert SM, Ausman LM:Influence of hydrogenated fat and butter onCVD risk factors: remnant-like particles,glucose and insulin, blood pressure andC-reactive protein. Atherosclerosis 171,97–107 (2003).
  • Salmeron J, Hu FB, Manson JE et al.:Dietary fat intake and risk of Type 2diabetes in women. Am. J. Clin. Nutr. 73,1019–1026 (2001).
  • Saravanan N, Haseeb A, Ehtesham NZ,Ghafoorunissa: Differential effects of dietary saturated and trans-fatty acids on expression of genes associated with insulin sensitivity inrat adipose tissue. Eur. J. Endocrinol. 153, 159–165 (2005).
  • Mozaffarian D, Pischon T, Hankinson SEet al.: Dietary intake of trans fattyacids and systemic inflammation in women. Am. J. Clin. Nutr. 79, 606–612(2004).
  • Lucas A: Programming by early nutrition:an experimental approach. J. Nutr. 128,401S–406S (1998).
  • Barker JD: The fetal and infant origins ofdisease. Eur. J. Clin. Invest. 25, 457–463(1995).
  • Harder T, Rodekamp E, Schellong K,Dudenhausen JW, Plagemann A:Birth weight and subsequent risk ofType 2 diabetes: a meta-analysis. Am. J.Epidemiol. 165, 849–857 (2007).
  • Lauren L, Jarvelin MR, Elliott Pet al.: Relationship between birthweightand blood lipid concentrations inlater life: evidence from the existing literature. Int. J. Epidemiol. 32, 862–876(2003).
  • Lucas A: Programming by early nutrition in man. Ciba Found. Symp. 156, 38–50;discussion 50–55 (1991).
  • Das NU: Is metabolic syndrome X adisorder of the brain with the initiation of low-grade systemic inflammatory events during the perinatal period? J. Nutr.Biochem. 18, 701–713 (2007).
  • Herrera E: Metabolic adaptations in pregnancyand their implications for the availability ofsubstrates to the fetus. Eur. J. Clin. Nutr. 54,S47–S51 (2000).
  • Herrera E: Implications of dietary fatty acids during pregnancy on placental, fetal andpostnatal development – a review. Placenta23(Suppl. A), S9–S19 (2002).
  • Harding EJ: The nutritional basis of thefetal origins of adult disease. Int. J.Epidemiol. 30, 15–23 (2001).
  • Ford SP, Hess BW, Schwope MM et al.:Maternal undernutrition during early tomid-gestation in the ewe results in altered growth, adiposity, and glucose tolerance inmale offspring. J. Anim. Sci. 85, 1285–1294(2007).
  • Langley SC, Browne RF, Jackson AA:Altered glucose tolerance in rats exposed tomaternal low protein diets in utero. Comp.Biochem. Physiol. Physiol. 109, 223–229(1994).
  • Lorenzo M, Caldes T, Benito M,Medina JM: Lipogenesis in vivo in maternaland foetal tissues during late gestation in therat. Biochem. J. 198, 425–428 (1981).
  • Neary RH, Kilby MD, Kumpatula P et al.:Fetal and maternal lipoprotein metabolism in human pregnancy. Clin. Sci. (Lond). 88,311–318 (1995).
  • Vuorio AF, Miettinen TA, Turtola H,Oksanen H, Gylling H: Cholesterolmetabolism in normal and heterozygousfamilial hypercholesterolemic newborns.J. Lab. Clin. Med. 140, 35–42 (2002).
  • Herrera E, Lasuncion MA: Maternal–fetaltransfer of lipid metabolites. In: Fetal andNeonatal Physiology. Polin RA, Fox WW,Abman SH (Eds). Saunders, PA, USA2855–2865 (2004).
  • Herrera E, Amusquivar E, Lopez-Soldado I,Ortega H: Maternal lipid metabolism andplacental lipid transfer. Horm. Res.65(Suppl. 3), 59–64 (2006).
  • Napoli C, D’Armiento FP, Mancini FPet al.: Fatty streak formation occurs inhuman fetal aortas and is greatly enhancedby maternal hypercholesterolemia – intimalaccumulation of low density lipoprotein andits oxidation precede monocyte recruitmentinto early atherosclerotic lesions. J. Clin.Invest. 100, 2680–2690 (1997).
  • Gerber RT, Holemans K, O’Brien-Coker Iet al.: Cholesterol-independent endothelial dysfunction in virgin andpregnant rats fed a diet high in saturatedfat. J. Physiol. 517(Pt 2), 607–616(1999).
  • Khan IY, Dekou V, Douglas G et al.:A high-fat diet during rat pregnancy orsuckling induces cardiovascular dysfunctionin adult offspring. Am. J. Physiol. Regul.Integr. Comp. Physiol. 288, R127–R133(2005).
  • Siemelink M, Verhoef A, Dormans JA,Span PN, Piersma AH: Dietary fatty acidcomposition during pregnancy and lactationin the rat programs growth and glucosemetabolism in the offspring. Diabetologia45, 1397–1403 (2002).
  • Herrera E, López-Soldado I, Limones M,Amusquivar E, Ramos MP: Lipidmetabolism during the perinatal phase andits implication on postnatal development.Int J. Vitam. Nutr. Res. 76, 216–224 (2006).
  • Ailhaud G, Guesnet P: Fatty acidcomposition of fats is an early determinantof childhood obesity: a short review and anopinion. Obes. Rev. 5, 21–26 (2004).
  • Sugano M, Ikeda I: Metabolic interactionsbetween essential and trans-fatty acids. Curr.Opin. Lipidol. 7, 38–42 (1996).
  • Larque E, Garcia-Ruiz PA, Perez-Llamas F,Zamora S, Gil A: Dietary trans fatty acidsalter the compositions of microsomes andmitochondria and the activities ofmicrosome 6-fatty acid desaturase andglucose-6-phosphatase in livers of pregnantrats. J. Nutr. 133, 2526–2531 (2003).
  • Das NU: A defect in the activity of 6 and 5 desaturases may be a factor predisposingto the development of insulin resistancesyndrome. Prostaglandins Leukot. Essent.Fatty Acids 72, 343–350 (2005).
  • Moore CE, Dhopeshwarkar GA: Placentaltransport of trans fatty acids in the rat. Lipids15, 1023–1028 (1980).
  • von Houwelingen AC, Hornstra G: Transfatty acids in early human development.World Rev. Nutr. Diet. 75, 175–178 (1994).
  • Hornstra G, van Eijsden M, Dirix C,Bonsel G: Trans fatty acids and birthoutcome: some first results of the MEFABand ABCD cohorts. Atheroscler. Suppl. 7,21–23 (2006).
  • van Eijsden M, Hornstra G,van der Wal MF, Vrijkotte TG, Bonsel GJ:Maternal n-3, n-6, and trans fatty acid profile early in pregnancy and term birthweight: a prospective cohort study. Am. J.Clin. Nutr. 87, 887–895 (2008).
  • Morrison JA, Glueck CJ, Wang P: Dietarytrans fatty acid intake is associated withincreased fetal loss. Fertil. Steril. 90(2),385–390 (2007).
  • Assumpcao RP, Santos FD, Setta CL et al.:Trans fatty acids in maternal diet may impairlipid biosynthesis in mammary gland of lactating rats. Ann. Nutr. Metab. 46,169–175 (2002).
  • Assumpcao RP, dos Santos FD,de Mattos Machado Andrade P, Barreto GF,das Gracas Tavares do Carmo M: Effect ofvariation of trans-fatty acid in lactating rats’diet on lipoprotein lipase activity inmammary gland, liver, and adipose tissue.Nutrition 20, 806–811 (2004).
  • Hornstra G: Essential fatty acids in mothersand their neonates. Am. J. Clin. Nutr. 71,1262S–1269S (2000).
  • Rosen BS, Cook KS, Yaglom J et al.: Adipsinand complement factor activity D: animmune-related defect in obesity. Science244, 1483–1487 (1989).
  • Hotamisligil GS, Shargill NS,Spiegelman BM: Adipose expression oftumor necrosis factor- : direct role inobesity-linked insulin resistance. Science259, 87–90 (1993).
  • Alessi MC, Peiretti F, Morange P, Henry M,Nalbone G, Juhan-Vague I: Production ofplasminogen activator inhibitor 1 by humanadipose tissue: possible link between visceralfat accumulation and vascular disease.Diabetes 46, 860–867 (1997).
  • Sawdey MS, Loskutoff DJ: Regulation ofmurine type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction bylipopolysaccharide, tumor necrosis factor- ,and transforming growth factor- . J. Clin.Invest. 88, 1346–1353 (1991).
  • Xu H, Barnes GT, Yang Q et al.: Chronic inflammation in fat plays a crucial role inthe development of obesity-related insulinresistance. J. Clin. Invest. 112, 1821–1830(2003).
  • Silva AP, Guimaraes DE, Mizurini DMet al.: Dietary fatty acids early in life affectlipid metabolism and adiposity in youngrats. Lipids 41, 535–541 (2006).
  • Pisani LP, Oyama LM, Bueno AA et al.:Hydrogenated fat intake during pregnancyand lactation modifies serum lipid profile and adipokine mRNA in 21-day-old rats.Nutrition 24, 255–261 (2008).
  • Segarra A, Chacon P, Martinez-Eyarre Cet al.: Circulating levels of plasminogenactivator inhibitor type-1, tissueplasminogen activator, andthrombomodulin in hemodialysis patients:biochemical correlations and role asindependent predictors of coronary arterystenosis. J. Am. Soc. Nephrol. 12,1255–1263 (2001).
  • Alessi MC, Juhan-Vague I: PAI-1 and themetabolic syndrome: links, causes, andconsequences. Arterioscler. Thromb. Vasc.Biol. 26, 2200–2207 (2006).
  • Shillabeer G, Lau DC: Regulation of new fatcell formation in rats: the role of dietary fats.J. Lipid Res. 35, 592–600 (1994).
  • Das NU: Pathophysiology of metabolicsyndrome X and its links to the perinatalperiod. Nutrition 21, 762–773 (2005).
  • Das NU: Perinatal supplementation of longchainpolyunsaturated fatty acids, immuneresponse and adult diseases. Med. Sci. Monit.10, HY19–HY25 (2004).
  • Das NU: Can essential fatty acids reduce theburden of disease(s)? Lipids Health Dis. 7, 9(2008).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.